177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial

Swayamjeet Satapathy; Chandan K. Das; Shikha Goyal; Ashwani Sood; Kannan Periasamy; Piyush Aggarwal; Komal Preet; Shrawan K. Singh; Ravimohan S. Mavuduru; Girdhar S. Bora; Aditya P. Sharma; Gaurav Prakash; Rajender Kumar; Harmandeep Singh; Bhagwant R. Mittal

doi:10.2967/jnumed.125.269913

Research ArticleClinical Investigation

¹⁷⁷Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial

Swayamjeet Satapathy, Chandan K. Das, Shikha Goyal, Ashwani Sood, Kannan Periasamy, Piyush Aggarwal, Komal Preet, Shrawan K. Singh, Ravimohan S. Mavuduru, Girdhar S. Bora, Aditya P. Sharma, Gaurav Prakash, Rajender Kumar, Harmandeep Singh and Bhagwant R. Mittal

Journal of Nuclear Medicine May 2025, jnumed.125.269913; DOI: https://doi.org/10.2967/jnumed.125.269913

Swayamjeet Satapathy

1Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Chandan K. Das

2Department of Clinical Haematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

3Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shikha Goyal

4Department of Radiotherapy and Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ashwani Sood

1Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kannan Periasamy

4Department of Radiotherapy and Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

5Department of Radiation Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Piyush Aggarwal

1Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Komal Preet

1Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shrawan K. Singh

6Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ravimohan S. Mavuduru

6Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Girdhar S. Bora

6Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aditya P. Sharma

6Department of Urology, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gaurav Prakash

2Department of Clinical Haematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rajender Kumar

1Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Harmandeep Singh

1Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bhagwant R. Mittal

1Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 6

June 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

¹⁷⁷Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial

Journal of Nuclear Medicine May 2025, jnumed.125.269913; DOI: 10.2967/jnumed.125.269913

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

¹⁷⁷Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial

Journal of Nuclear Medicine May 2025, jnumed.125.269913; DOI: 10.2967/jnumed.125.269913

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

177Lu-PSMA-617
androgen-deprivation therapy
docetaxel
high-volume
metastatic hormone-sensitive prostate cancer

Main menu

User menu

Search

¹⁷⁷Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords